BRCA1 and ovarian carcinoma: In contrast, other NGS analysis of BRCA1/2 mutations in ovarian cancer demonstrated 100% concordance between the tumor and ctDNA germline variants, but this was not observed in the case of somatic variants, indicating the intratumor heterogeneity.44